Latest Breaking News On - Lauren ballinger - Page 1 : vimarsana.com

<p>Leukaemia trial shows &#39;exceptional&#39; resultsPersonalised treatment for the most common form of adult leukaemia helps patients survive for longer and stay in remission, a phase III trial has found.</p> <p>Adult patients were given a combination of cancer growth blocking drugs over varied durations depending on how rapidly their disease responded.&nbsp;&nbsp;</p> <p>More than 19 in 20 patients were in remission three years after starting treatment - a significant improvement in progression-free and overall survival compared to standard treatment.</p> <p>Study lead Professor Peter Hillmen said: &ldquo;The results of the FLAIR Trial, led by the Leeds Cancer Research UK Clinical Trials Unit at the University of Leeds, are exceptional and herald a change in the way chronic lymphocytic leukaemia will be treated.&rdquo;</p>

United kingdomUnited statesSan diegoFacebook linkedin instagraLauren ballingerRosalind franklinDavid cairnsIain foulkesRussell groupJanssen research developmentAbbvie pharmaceutical researchCancer research united kingdomLeeds cancer research united kingdomAmerican society of haemotologyUniversity of leedsUniversity of leed school medicine